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Genetic Divergence Between the Wistar-Kyoto
Rat and the Spontaneously Hypertensive Rat
Mark L. Johnson, Daniel L. Ely, and Monte E. Turner
A method of restriction fragment length polymorphism (RFLP) analysis was used to estimate the amount
of genetic divergence between the spontaneously hypertensive rat (SHR) strain and the Wistar-Kyoto
(WKY) strain. DNA from each strain was digested with eight restriction endonucleases and hybridized
with six single copy gene sequences. The number of hybridization bands in each digestion was used to
estimate the total number of bases analyzed and RFLPs were scored as single mutations. Divergence was
then estimated by dividing the number of mutations by the number of bases analyzed. In a total of 808
bases analyzed in WKY rats, a minimum of 13 mutations were scored in SHR, which yields a nucleotide
divergence of 1 change per 62 bp. This is an extremely high amount of divergence given the known origin
of these two strains and is comparable to the maximum divergence possible between unrelated humans.
(Hypertension 1992;19:425-427)
KEY WORDS • genetics • genetic divergence • spontaneously hypertensive rats • Wistar-Kyoto
rats • genetic hypertension

T

he spontaneously hypertensive rat (SHR) has
been, since its release as an inbred strain in
1969, the most extensively studied of all animal
models for human essential hypertension.' The SHR
strain was the result of selection for increased blood
pressure from an outbred Wistar colony at Kyoto University.2^ In 1970, a second strain was derived from the
same outbred Wistar colony without selection for blood
pressure; this strain was designated Wistar-Kyoto
(WKY).3 The WKY strain has been used extensively as
a normotensive control for the hypertensive SHR strain.
DNA "fingerprints" differentiate SHR and WKY rats
from each other*-6 and also identify substrains (isolates) within the SHR4 and WKY 56 strains. As efforts to
identify genes responsible for hypertension increase, a
number of laboratories have set up crosses between
WKY rats and SHR in an attempt to segregate specific
genes with blood pressure.7 The usefulness of such
crosses between SHR and WKY rats has recently come
under serious scrutiny.5"8 One problem is the lack of
basic genetic background knowledge concerning these
two strains. How genetically similar or dissimilar are
these two strains? The DNA fingerprint data demonstrate a qualitative difference but have not been used to
quantify this relation. Although both strains were derived from the same colony, the selection methods
applied to each strain and the times of derivation (1960
for SHR versus 1970 for WKY) were different. Therefore, it is not obvious how much genetic variation exists
between the two strains. Physiological and descriptive
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studies have described numerous phenotypic differences between SHR and WKY (see Reference 9 for a
review). Are these differences the pleiotropic effects of
a few variable loci, or are there many loci that differ
between the strains?
In the current study, we quantify the genetic differentiation at the nucleotide level between the SHR and
WKY strains. We used a protocol that examined strain
differences in the restriction fragment patterns of single
copy genes with no a priori potential to affect blood
pressure. From this data we have been able to calculate
the nucleotide divergence between the SHR and WKY
rat. A better knowledge of the genetic relatedness of the
strains is necessary for designing crosses to study and
identify those loci affecting blood pressure.
Methods
Rat Strains
The SHR and WKY strains used in our studies were
originally obtained from Harlan Sprague Dawley, Indianapolis, Ind., who obtained their breeding stock from
the National Institutes of Health (NIH). We have
maintained and inbred these strains in our animal
facilities for over 10 years with approximately three to
four generations per year. The animals were maintained
in a humane manner according to NIH guidelines.
Restriction Fragment Length Polymorphism Analysis
DNA was isolated from SHR and WKY rat livers
according to the method of Johnson et al.10 The DNA
was dissolved in distilled, deionized water and stored
frozen at -20°C in 300 -jig aliquots. Restriction enzymes (BamHl, EcoRl, Hindlll, Msp I, Pst I, Pvu II, Taq
I, and Xba I) were purchased from BRL (Life Technologies, Inc., Grand Island, N.Y.), and digests were
performed according to supplier recommendations. For
each enzyme, 300 tig SHR and WKY DNA was digested

Downloaded from http://hyper.ahajournals.org/ by guest on March 25, 2014

426

Hypertension

Vol 19, No 5 May 1992

using 4-6 units of enzyme per microgram DNA. Fifteen
micrograms digested DNA was loaded in each lane of
an 0.8% agarose gel. Electrophoresis was conducted for
16-18 hours in Tris-acetate buffer.10 Twenty duplicate
gels were produced. DNA size standards were included
on each gel (1 kb ladder, BRL). After electrophoresis,
gels were stained with ethidium bromide, photographed, transferred to Zetabind membrane (Whatman
Lab Sales, Hillsboro, Ore.), and hybridized as described
by the supplier. Cloned DNA probes for the RFLP
analysis were obtained from ATCC (y-abl, No. 41035;
v-bas, No. 41036; hypoxanthine-guanine phosphoribosyl
transferase [HPRT], No. 37424) or were the generous
gift of various investigators (rat L-pyruvate kinase complementary DNA [cDNA] clone G4, Dr. Axel Kahn; i *
aromatase cDNA, Dr. JoAnne Richards; rat B-caseii.
cDNA, Dr. Jeffrey Rosen). All cloned DNAs were nick
translated and labeled with phosphorus-32 as described
by Rodgers et al11 to a final specific activity of 100150x10* cpm/Mg DNA. Probe concentration in the
hybridizations was adjusted to give between 1 and 2x 106
cpm/ml buffer. The final formamide concentration was
adjusted to 40% in hybridizations involving non-rat
cloned DNA probes. After hybridization, filters were
washed using stringencies consistent with the hybridization conditions. Autoradiography was performed using
Du Pont Cronex Lighting Plus intensifying screens (Du
Pont Co., Wilmington, Del.) for 5-9 days at -70°C.
Nucleotide Divergence Analysis
WKY DNA was arbitrarily chosen as the point of
reference for this analysis. First, we determined the number (N) of hybridization bands detected for each digest
that gave clear signals. To generate these N bands, N+1
restriction sites are required. The number of restriction
sites was multiplied by the number of nucleotides in the
recognition sequence for that enzyme to give the number
of bases screened. The sum of all bases for each enzyme
for each probe gave an estimate of the total number of
bases screened in the WKY DNA.
For the purpose of our analysis, a restriction fragment length polymorphism (RFLP) was defined as a
difference in the hybridization banding patterns between SHR and WKY for a given enzyme. For each
RFLP detected, we assumed that a single point mutation was responsible. However, in the computation of
divergence only one mutation was scored for any given
enzyme digest, regardless of how many RFLPs were
detected. Dividing the total number of bases screened in
the WKY DNA by the number of scored mutations
gives an estimate of the frequency of nucleotide changes
between these colonies of SHR and WKY rats. This
value is a minimum estimate of nucleotide divergence
based on our assumptions.
Results
The objective of the present study was to establish the
genetic relatedness, at a molecular level, of the SHR
and WKY rat strains. Table 1 lists the probes tested and
the results of our divergence analysis. Each of the six
different probes detected at least one RFLP with our
panel of eight restriction enzymes. A total of 808 bases
were analyzed, and a minimum of 13 mutations were

TABLE 1. Summary of Restriction Fragment Length Polymorphism Analysis and Estimation of Divergence Estimate

Probe
v-flW

v-bas
L-Pyruvatc
kinase

Enzymes
detecting Mutations Bases Divergence
scored
RFLPs
analyzed estimate
1 per 40
3
120
EcoRI
Hindlll
Xba I
2
1 per 69
138
EcoRI
Xba I
2

132

1 per 66

3

170

1 per 57

2

98

1 per 49

1

150

1 per 150

13

808

1 per 62

EcoRI
Xba I

HPRT

B-casein
Aromatase
Total

EcoRI
Taql
Xbal
EcoRI
HindlU
BamHl

For each probe tested, the enzymes detecting restriction fragment length polymorphisms (RFLPs) are listed along with the
number of mutations scored for each probe and the number of
bases analyzed. Divergence frequency is calculated by dividing
mutations scored by the number of bases analyzed. Method for
calculating bases analyzed and mutations scored is described in
"Methods."

scored. This equates to an average nucleotide divergence of 1 change per 62 bp.
The estimates of divergence for each individual probe
can be used to calculate a 95% confidence interval for
the overall estimate. The mean divergence calculated in
this way is 1 in 61 with a 95% confidence interval of
from 1/42 to 1/105.
Discussion
A number of RFLPs have been reported in the
literature with respect to genes that are postulated to
play a role in hypertension (see Reference 12 for an
example). To prevent bias in our analysis, a series of
random, single-copy DNA probes were chosen that a
priori could be predicted to have no relation to blood
pressure differences reported between the SHR and
WKY strains. Also, the eight restriction enzymes used
recognize a total of 46 bp, of which 24 are GC and 22 are
AT. All restriction enzymes do not equally identify
polymorphisms. In mammalian studies, Msp I and Taq I
detect an excessively high number of polymorphisms
compared with other restriction endonucleases.13 Both
of these enzymes have CpG dinucleotides in their
recognition sequences, and this CpG sequence is known
to undergo a C to T transition at increased frequency.14
Of the RFLPs detected in the present study, only one
was identified from either Msp I or Taq I digestions.
Therefore, our analysis is not inadvertently biased toward any particular subset of DNA sequences or nucleotides with increased mutation rates and is reflective of
a random sample.
The divergence as estimated from individual probes was
relatively constant (Table 1); the highest divergence was 1
base pair in 40 with v-abl, and the lowest divergence was 1
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base pair in 150 with aromatase. All the other estimates
were between 1 in 49 and 1 in 69. Although the absolute
value of the frequency we obtained is subject to our
implicit assumptions, which may not be totally valid (for
instance the assumption that only one base pair change
was responsible for each RFLP), the conformity of estimates from probe to probe would indicate these assumptions are at least consistent.
Studies to estimate nucleotide divergence in human
populations calculate average heterozygosity.15'16 Measures of average heterozygosity are weighted by the gene
frequencies of the identified variants. In comparisons
between two inbred strains such as SHR and WKY, all
variants are assumed to have a gene frequency of either 1
or 0 depending on the reference strain. The value calculated between SHR and WKY rats is not an average
heterozygosity but is the measured heterozygosity.
Values of average heterozygosity between unrelated
humans are about 1 in 300,1516 which is less than that
calculated for SHR and WKY rats. Another comparison
with the human data would be to use polymorphic sites
rather than average heterozygosity. This would measure
the maximum heterozygosity in the human population.
Hofker et al16 used 40 unique or single-copy autosomal
probes and assayed 2,710 bp of DNA in unrelated individuals and found 24 polymorphic sites, which is an
average of 1 site in 113 bp. Murray et al17 found eight sites
in 689 bp or an average of 1 in 86. Our data suggest that
WKY rats and SHR differ from each other as much as the
maximum value possible for two unrelated humans.
SHR and WKY rats have been separated from the
original colony and each other for at least 30 years. Some
of the divergence we measured could have occurred since
the strains were derived rather than having been present
at their origin. Two lines of data can be used to estimate
this form of divergence. From the time of divergence (30
years) and an estimate of mutation rate (5x10 substitutions per nucleotide per year),18 the frequency of new
mutations can be calculated using the equation
/L=(mutation rate)(time)
where K is the frequency of new mutations. This would
predict a single base change per 6.7 million bp; therefore, given the number of bases we assayed, we would
not expect to see any new mutations. As discussed
previously, the first type of mutation to accumulate
between the strains should be the CpG variation detected by Msp I and Taq I. Since only 1 RFLP was
detected with these enzymes, most if not all, of the
polymorphisms identified in the present study were
probably present in the original outbred colony rather
than the result of new mutations that occurred since the
inbred strains were separated from the parental colony.
What does our analysis imply with respect to the
search for hypertension genes in the SHR strain? First,
the simple identification of an RFLP does not guarantee
linkage to hypertension. In fact, our data suggest that
any gene is likely to have at least one or more RFLP
associated with it between SHR and WKY rats. This
reinforces the admonition of Rapp that proper linkage/
segregation analysis and mechanistic relevance must be
demonstrated to establish a relation between a RFLP
and hypertension.7'19 Second, it raises the question of
how related are SHR and WKY rats in different colo-
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nies that have been maintained throughout the world?
Our data are not intended to measure the genetic
differentiation within either SHR or WKY rat strains.
However, given the amount of genetic variation we
observed in our colonies, it would not be surprising to
find substantial divergence between SHR and/or WKY
rats maintained in our colony versus the same strain
maintained in colonies elsewhere. Could discrepancies
in results between laboratories be due to the genetic
variation that probably exists? Further analysis of SHR
and WKY rat isolates from other colonies will need to
be performed to answer these questions.
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